Skip to main content
QTI
NASDAQ Industrial Applications And Services

QT Imaging Projects $39M Revenue for 2026, Secures CPT Code & Expands Globally

Analysis by Wiseek.ai
Sentiment info
Positive
Importance info
9
Price
$5.49
Mkt Cap
$65.343M
52W Low
$0.324
52W High
$8.5
Market data snapshot near publication time

summarizeSummary

QT Imaging Holdings, Inc. released an investor presentation detailing strong Q4/FY25 financial results, projecting $39 million in 2026 revenue, and announcing a new Category III CPT code approval, alongside significant international distribution agreements.


check_boxKey Events

  • Record Q4 and FY25 Revenue

    The company achieved record commercial revenue of $8.3 million in Q4 2025 (877% YOY growth) and $18.9 million for the full year 2025, exceeding its guidance of $18.0 million.

  • Strong 2026 Revenue Guidance

    QT Imaging projects approximately $39 million in revenue for 2026, driven by scanner shipments and initial revenue from its SaaS Cloud Platform.

  • New CPT Code Approval

    The AMA approved a new Category III CPT code (X579T) in February 2026, scheduled for release on July 1, 2026, with an effective date of January 1, 2027, recognizing the company's 3D breast imaging platform.

  • International Market Expansion

    Secured distribution agreements with NXC Imaging (USA), Gulf Medical (KSA), and Al Naghi Medical (UAE), including committed minimum order quantities for scanner shipments through 2028.


auto_awesomeAnalysis

This filing, an investor presentation, provides significant updates following the company's Q4 and full-year 2025 financial results announced on February 18, 2026. The company reported record 2025 revenue of $18.9 million, surpassing its guidance. Crucially, QT Imaging Holdings projects approximately $39 million in revenue for 2026, a substantial increase that represents roughly 60% of its current market capitalization. This ambitious guidance is bolstered by the recent approval of a new Category III CPT code (X579T) by the AMA, effective January 1, 2027, which is a critical step for future reimbursement and commercialization of its breast imaging technology. Furthermore, the company has secured significant distribution agreements with committed minimum order quantities in the USA, Saudi Arabia, and the UAE, indicating strong international expansion. The strategic shift towards a hardware-plus-SaaS platform also positions the company for sustainable, data-centric growth. Investors should monitor the execution of these commercial agreements and the progress towards full CPT code implementation.

At the time of this filing, QTI was trading at $5.49 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $65.3M. The 52-week trading range was $0.32 to $8.50. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed QTI - Latest Insights

QTI
Mar 27, 2026, 4:31 PM EDT
Filing Type: S-3
Importance Score:
9
QTI
Mar 25, 2026, 8:13 AM EDT
Filing Type: 8-K
Importance Score:
8
QTI
Mar 25, 2026, 8:02 AM EDT
Filing Type: 10-K
Importance Score:
8
QTI
Mar 25, 2026, 8:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
QTI
Feb 25, 2026, 4:06 PM EST
Filing Type: 8-K
Importance Score:
9
QTI
Feb 18, 2026, 8:41 AM EST
Filing Type: 8-K
Importance Score:
9
QTI
Feb 06, 2026, 4:40 PM EST
Filing Type: 8-K
Importance Score:
8
QTI
Jan 28, 2026, 6:02 PM EST
Filing Type: 424B3
Importance Score:
8